Pharmaceutical composition for thrombin peptide derivatives
Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-pro...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | HOBSON DAVID W TANG ANDREW P.K CROWTHER ROGER S CARNEY DARRELL H |
description | Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2005203017A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2005203017A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2005203017A13</originalsourceid><addsrcrecordid>eNrjZLAOyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMz1NIyy9SKMkoys9NysxTKEgtKMlMSVVISS3KLEssySxLLeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBUBT81JL4kODjQwMTI0MjA0MzR0NjYlTBQDaEzEw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical composition for thrombin peptide derivatives</title><source>esp@cenet</source><creator>HOBSON DAVID W ; TANG ANDREW P.K ; CROWTHER ROGER S ; CARNEY DARRELL H</creator><creatorcontrib>HOBSON DAVID W ; TANG ANDREW P.K ; CROWTHER ROGER S ; CARNEY DARRELL H</creatorcontrib><description>Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050915&DB=EPODOC&CC=US&NR=2005203017A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050915&DB=EPODOC&CC=US&NR=2005203017A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HOBSON DAVID W</creatorcontrib><creatorcontrib>TANG ANDREW P.K</creatorcontrib><creatorcontrib>CROWTHER ROGER S</creatorcontrib><creatorcontrib>CARNEY DARRELL H</creatorcontrib><title>Pharmaceutical composition for thrombin peptide derivatives</title><description>Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAOyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMz1NIyy9SKMkoys9NysxTKEgtKMlMSVVISS3KLEssySxLLeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBUBT81JL4kODjQwMTI0MjA0MzR0NjYlTBQDaEzEw</recordid><startdate>20050915</startdate><enddate>20050915</enddate><creator>HOBSON DAVID W</creator><creator>TANG ANDREW P.K</creator><creator>CROWTHER ROGER S</creator><creator>CARNEY DARRELL H</creator><scope>EVB</scope></search><sort><creationdate>20050915</creationdate><title>Pharmaceutical composition for thrombin peptide derivatives</title><author>HOBSON DAVID W ; TANG ANDREW P.K ; CROWTHER ROGER S ; CARNEY DARRELL H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2005203017A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HOBSON DAVID W</creatorcontrib><creatorcontrib>TANG ANDREW P.K</creatorcontrib><creatorcontrib>CROWTHER ROGER S</creatorcontrib><creatorcontrib>CARNEY DARRELL H</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HOBSON DAVID W</au><au>TANG ANDREW P.K</au><au>CROWTHER ROGER S</au><au>CARNEY DARRELL H</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical composition for thrombin peptide derivatives</title><date>2005-09-15</date><risdate>2005</risdate><abstract>Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2005203017A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Pharmaceutical composition for thrombin peptide derivatives |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T22%3A19%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HOBSON%20DAVID%20W&rft.date=2005-09-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2005203017A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |